Eight medicines set to receive EU approval from CHMP

The European Medicines Committee’s human medicines committee (CHMP) has backed approval of eight new medicines across a range of indications. Gilead’s remdesivir has been previously recommended for conditional approval for treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen. The drug is the first medicine against

Continue Reading